Farmingdale, NY, January 24, 2015 --(PR.com
)-- Dr. Schiestl’s illustrious career began in Austria where he earned his PhD in biology at the University of Vienna in the Department of Cancer Research in 1983. He was the Universitäts Assistant there for a short time after which he pursued his post doctoral studies in the Department of Biology at the University of Alberta in Edmonton, Alberta, Canada until 1986. He then went to the University of Rochester, New York, where he was a Postdoctoral Fellow in biology from 1986 to 1989. Dr. Schiestl continued his career at the University of North Carolina in Chapel Hill, North Carolina where he was an assistant researcher in the Department of Biology from 1989 to 1991. From there, we went on to become the associate professor at the Harvard School of Public Health. He is currently a professor at UCLA as Professor of Pathology, Laboratory Medicine, Radiation Oncology and Environmental Health Sciences. He specializes in the molecular basis of cancer. In addition to his other accomplishments, Dr. Schiestl was Brainpower Austria Guest Professor in the Department of Cancer Research at the Medical University of Vienna from 2008-2011. He has 180 publications to his credit, 5 press releases and 10 patents. Among his 3 start up companies are Micro Pharma, Inc. and RadMit Pharma, LLC which are located in Los Angeles. RadMit, Pharm GesmbH is located in Austria. He is in the process of starting a 4th. He is affiliated with the Society of Toxicology and, in his leisure time, he enjoys fishing, hiking and animals.
The Professional of the Year membership in America’s Registry is awarded to those candidates who have achieved recognition in their respective industry or profession for their accomplishments and who have established a commendable reputation. This membership honors individuals who have reached the highest standards of business practices and, as such, should be recognized for their standings in the business world. America’s Registry is pleased to award this honor to Robert H. Schiestl, PhD.